Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced results from new post hoc analyses of the HELIOS-B Phase 3 study of AMVUTTRA® (vutrisiran), an RNAi ...
Abstract The prevalence of multiple sexual partners (MSPs) remains high worldwide, with sub-Saharan Africa reporting some of ...
Hyatt’s technicals maintain its bullish signals after rebounding from its most recent low of $134. It now trades above the 50 ...
Emotional distress among adolescents in most participating countries was higher in 2022 than in 2018, with disproportionate ...
Existing frameworks like the U.S. Environmental Protection Agency’s Energy Star Portfolio Manager provide useful performance ...
WRN inhibitors are attracting increasing attention as a niche but fast-emerging segment within precision oncology, driven by ...
While self-healing agentic test suites can help eliminate the manual intervention consuming engineering cycles, there are key ...
Scientists used drones to sample the breath of whales and showed that the microbes in that breath track the animals’ health.
Conclusions: There is a potential mismatch between what clinicians identify as important in determining palliative care need and final eligibility determinations. Patients with dementia were less ...